Beste Biopsie Gastroenterologen - TOP-287 Ärzte

Dr. Raj ist ein sehr erfahrener chirurgischer Onkologe mit 19 Jahren Erfahrung und über 50.000 durchgeführten Krebsoperationen. Er ist an zahlreichen klinischen Studien beteiligt und hat viele internationale und nationale Veröffentlichungen zu seinem Verdienst. Er ist spezialisiert auf Brust- und Thorax-Chirurgie-Onkologie und Professor für DNB Superspecialty Surgical Oncology and Breast Surgery an der Maharashtra University of Health Sciences. Sein Glaube ist, „den Jahren Leben hinzuzufügen“ und die Lebensqualität zu verbessern, nicht nur dem Leben Jahre hinzuzufügen.

Prof. Songul Serefhanoglu ist seit 2019 Hämatologe am ISU Medical Park und seit 2019 Direktor und Präsident der Abteilung für Erwachsenenhämatologie des Sisli Memorial Hospital, Istanbul. Er absolvierte seine medizinische Ausbildung an der Firat University, Elazig/Türkei (1994-2000). ), Innere Medizin von der Inonu University, Malatya/Türkei (2001-2005) und Hämatologie von der Hacettepe University, Ankara/Türkei (2006-2009). Er war an der Transplantation peripherer hämatopoetischer Stammzellen beteiligt, mit durchschnittlich 100-120/Jahr.

Dr. Hosam is a Consultant Obstetrician, Gynecologist, and Urologist. He worked for 20 years in the NHS in the United Kingdom after obtaining his CCST as a Consultant Gynecologist with known expertise in the management of high-risk pregnancy, complex benign gynecology, and early-stage gynecological cancer. He worked as a Consultant and the Lead Urogynecologist at Sussex Healthcare Trust, where he has been practicing since 2004. Dr. Hosam has a special interest in prolapse, urinary incontinence, sexual dysfunction (fertility preservation surgery), menorrhagia, and minimally invasive laparoscopic and hysteroscopic gynecological surgery (for abnormal bleeding, pelvic masses, and pelvic pain). He established an integrated multidisciplinary urogynecology team across the trust. He had led the obstetrics and gynecology department as a clinical director to attain national British Society of Urogynecology accreditation. He has extensive clinical and surgical expertise to manage urinary incontinence, frequency, urgency, and recurrent cystitis and to perform pelvic reconstructive surgery for incontinence and uterovaginal prolapse. A subjective retrospective audit of his continence surgery showed a success rate of 86% and a success rate of prolapsed surgery of 91%. He is also interested in the management of sexual dysfunction, including vaginal corrective surgery. Dr. Hosam was chosen to be a Member of the International Urogynecology Association’s Publication Committee, and he was also the Editor of the expert corner in the IUGA newsletter. His areas of expertise include,

• Minimally invasive laparoscopic and hysteroscopic surgery
• Menorrhagia, fibroid, and endometriosis
• Laparoscopic myomectomy and hysterectomy
• Urogynecology, pelvic floor surgery, and recurrent prolapse
• Female stress incontinence surgery
• High-risk pregnancy
• Prolapse and pelvic floor surgery
• Pelvic reconstruction surgery
• Stress incontinence treatment
• Urodynamics
• Urogynecology
• Endometriosis
• Fibroids
• Hysteroscopy
• Menopause and psychosexual problems
• Menorrhagia
• Laparoscopic hysterectomy and myomectomy
• Stress incontinence surgery (none mesh and minimally invasive procedures)
• Day case stress incontinence procedure without surgery
• Anal sphincter incontinence surgery
• Abdominal and vaginal suspension procedures
• Menstrual disorders
• Miscarriage
• Painful periods
• Pelvic/perineal pain
• Postpartum obstetric anal sphincter injuries

Research & Publications

• Serum Cupper and Zinc in Unexplained Infertility
• Anti HLA Abs in Recurrent Miscarriage and Effect of Immune Therapy on Pregnancy Outcomes
• Unusual presentation of PRESS in the postnatal period. BMJ Case Reports 2014; doi:10.1136/bcr-2013-203406
• Subphrenic abscess resulting in multi organ failure after Caesarean Section - case report. J. of obstet&Gynae.Vol 30; No.3,312-314,2010.
• Long Term outcome of the telephone follow up clinic in gynaecological setting. Int. J. of healthcare administration.vol 7, No.1.,2010.
• Role of 3D ultrasound in the diagnosis of rare case of angular pregnancy. The Internet Journal of Gynaecology and Obstetrics. 2009 Volume 11 Number 2.
• Unusual presentation of ectopic pregnancy. Therapeutic forum,MIMS Women's Health Vol 4,No 3,2009.
• Management of Ovarian Masses in Pregnancy. Trends in Gynaecology and Urology, Volume 14 Issue 1, p 14-17 (January/February 2009).
• Factors Affecting Success of Hysteroscopic Hydrothermablation Procedure: A One Year Data Assessment. Kent and Sussex Journal of Obstetrics and Gynaecology. Vol. 6, issue 2, Jan 2008.
• Value of the MRI in the Preoperative Assessment of the Endometrial Cancer. Int. J. of O&G, Vol. 8 No.2, December 2007.
• Perioperative Factors Affecting the Hysteroscopic Hydrothermablation Procedure: A Six-month Assessment. Obstetrics & Gynaecology, News J. March 2006.
• Evaluation of the Transvaginal Scan versus Hysteroscopy in Postmenopausal Bleeding. East Sussex Journal of O&G. March, 2006.
• Unusual Presentation of Cervical Ectopic Pregnancy. East Sussex Journal of O&G, March 2006.
• Reproductive Health of Women: A review of the Panoramic Heritage. The Alex Journal of History of Medicine. Vol 30 -33, issue 1, April 2005.
• The use of low molecular weight heparin in pregnant woman with Mitral valve heart disease. Kuwait Medical Journal, March 2002, vol.39, No.5, 53-54.
• Mean 3rd Trimester Blood Sugar in Diabetic Kuwaiti Pregnant Females as a Predictor for Fetal Macrosomia. Medscape Women’s Health, (United States), Oct 2001, 6(5) p2.
• Chronic Pelvic Pain in Women. Obstetric and Gynaecology Survey. November issue 2001.
• Autologus Fascial Sling ,Does it really help the stress incontinence ,One year outcome data.
• Outcome of the Bulkamid periurethral injection.Outcome of the Vaginal suspension procedure for the years 19/20/21
• Perioperative factors that affect the outcome of the pelvic floor surgery IUGA 2019
• MRI ,CT scan versus TVS in the diagnosis and management of adnexal mass over 3 years (Oral presentation at the international gynaecology and gynae-oncology in China) 2013
• Perioperative factors affecting the success of the HTA, a 3 years follow up at the 13th international world controversies in Ob.Gyn. and infertility, Berlin, Germany. 4-7/11/2010
• Is there is a place for uterine conservation in the management of early stage endometrial cancer. RCOG international conference Abu-Dhabi Dec. 6,7,8th 2009.
• Value of TVS in the initial assessment of high-risk postmenopausal women. Annual RCOG international conference Abu-Dhabi Dec. 2009-09-13 (Poster)
• Is there is a place for the local hysteroscopic resection for malignant polypoidal endometrial cancer? Annual Southeast Gynaecology Tumour Group meeting. 17 September 2007. (oral)
• Value of the MRI, Hysteroscopy and TVS in the Preoperative Staging of Endometrial Cancer. 31st British International Congress of Obstetrics and Gynaecology 4-6 July/2007. (oral)
• Hysteroscopic Hydrothermablation: A novel Ablative Technique. Grand round oral presentation in the East Sussex NHS Trust monthly meeting.
• Evaluation of Perioperative Factors Affecting Success of Hysteroscopic Hydrothermablation Procedure. Presented at the BSGE Annual Scientific meeting in Sheffield, May 2006.
• Evaluation of the Transvaginal Scan versus Hysteroscopy in Postmenopausal Women on Tamoxifen . Poster Presentation at the 19th EBCOG European Congress of Obstetrics and Gynaecology, April 2006, Torino, Italy.
• Induced Abortion Services in a District General Hospital. Poster presentation at the North Middlesex University Hospital Meeting, London, 26th May 2006.
• Outcome of the Hysteroscopy at Conquest Hospital over the last triennium 2004-2005. Part of the special skill module of the TVS in Gynaecology for the RCOG. Presented at the world 7th controversies in Obstetrics and Gynaecology in Athens, April 2005.
• Perinatal Mortality Audit at Jahra Hospital, Kuwait. Accepted by the CPD program of the RCOG 2001.
• Audit of the Outcome of the Burch Colposuspension over a 2-year period. Oral Presentation at the Annual Obstetrics and Gynaecology Conference, Kuwait Institute of Medical Specialisation, Kuwait 2003, Jahra

Education & Training

• Master's Degree in Obstetrics and Gynaecology (Ain Shams University, Cairo, Egypt)
• FRCOG (Royal College of Obstetricians and Gynecologists) in the UK
• MD Doctorate Degree in Obstetrics and Gynecology (Ain Shams University, Cairo, Egypt)
• Royal College of Obstetrician and Gynecologist Subspecialty Modular training in Urogynaecology, minimally invasive laparoscopic and hysteroscopic surgery

Membership

• British Society of Gynae-Endoscopy
• British Society of Urogynaecology

Dr. Yuliia Kochet ist Geburtshelferin, Gynäkologin und Reproduktionslogin mit 17 Jahren Erfahrung und Spezialisierung erster Kategorie. Sie ist Mitglied der Ukrainischen Vereinigung für Reproduktionsmedizin (UARM) und der Europäischen Gesellschaft für Reproduktion und Embryologie und verfügt über Fachkenntnisse in assistierten Reproduktionstechnologien, Ultraschalldiagnostik, Hysterosalpingographie, Hysteroskopie, Laparoskopie, Radiowellenchirurgie und der Behandlung von Gebärmutterproblemen und sexuell übertragbaren Krankheiten. Sie hat Erfahrung mit internationalen Seminaren und Konferenzen.

Field of Speciality: Urology
Date of Birth: 1980
School of Medicine:  Istanbul University School of Medicine
Graduate Medical Education: University of Health Sciences Taksim Training & Research Hospital
Fellowship: Urological Oncology and Laparoscopic Urology Department of Urology SLK Kliniken Heilbronn University of Heidelberg, Germany
Foreign Language: English

Having graduated from Istanbul University, Faculty of Medicine in Istanbul, he pursued Urological Surgery residency at University of Health Sciences Taksim Training & Research Hospital, Istanbul from 2005 to 2010. He subsequently completed fellowship training in Urological Oncology and Laparoscopic Urology at Department of Urology, Heilbronn, Heidelberg University, Germany.Dr. Taş is able to provide patients curative surgery that is extremely precise, preserves sexual function, has minimal blood loss, minimal pain and quick recovery.

Firsts of Safe Urology Clinic in Turkey: Penis injections of:
Cellular derived from adipose tissue
Autologous bone marrow mesenchymal Cellular
Male-Shot

​

After graduating from Istanbul Medical Faculty in 2004, Dr. Tuncay Taş completed his specialization in Urology at Taksim Training and Research Hospital in 2010. After the training he received in 2006 and 2007 at the “Laparoscopy, Robotics and Oncology Center” of Heildelberg University, Heilbronn SLK Hospital, Germany, he continues to serve his patients in Turkey, especially in the field of Laparoscopic/Robotic Surgery. The majority of Tuncay Taş’s urology practice consists of man sexual health, cancer diagnosis and treatments

His sexual health and wellness practice offers cutting-edge technologies and treatment options for men. Dr Tas offers unique training and clinical protocols for practitioners who want to implement   Penile Implants , Penile Enhancement , SafeFill and MaleShot  into their practice. Dr Taş and his team presented the results of combined P.R.P (MALE-P-SHOT) and SVF application to the penis for the first time in Turkey at the scientific congress and shared the clinical results of these applications. It is also one of the first 5 centers in the world to publish the results of P.R.P (P.SHOT) applications. Dr Taş is one of the urology instructors at ISSCA who is fully involved in regenerative medicine.

(Source: At the congress organized by İHA International Cellular Therapies Association, Dr. Tuncay Taş shared his cell research in clinical regenerative medicine and erectile dysfunction. 2019, Sexual Medicine-Original Research2021, Apr;9(2):100313.doi:10.1016/j.esxm.2020.100313. Epub 2021 30 January.)

​

Recently Dr. Tas has developed a safe and effective treatment to improve penile circumference and has conducted training with a UK-based certification programme. This novel technique has been shown to have impressive and durable cosmetic results.

​

​

OTHER AREAS OF FOCUS

Robotic prostatectomy, Radical prostatectomy, HoLEP, Donor nephrectomy, Nephrectomy, Robotic surgery, Laparoscopic surgery, Prostate cancer, Kidney cancer, Bladder cancer, Testicular cancer, Retroperitoneal lymph node dissection for testicular cancer, Erectile dysfunction, Sexual dysfunction, Male infertility, Varicocelectomy, Male hypogonadism, Penile implant insertion, Urethroplasty, Penile reconstruction, Penile enlargement, Urethral reconstruction, Artificial urinary sphincter implantation, Bladder botox injection, Urodynamic testing, Bladder augmentation, Urinary diversion, Urethral stricture, Ureteral obstruction, HIPEC, Reconstructive surgery, Laparoscopic surgery, Fertility preservation, Minimally invasive surgery, Hypospadias

​

Membership of Scientific Organizations

Turkish Association of Urology
Turkish Medical Association
Association of Endourology
European Association of Urology
International Society for Stem Cells Applications

• Publications
https://scholar.google.com/citations?user=CA59D8UAAAAJ&hl=en

​

Representative doctor of Cheongdam Hifu Clinic·Radiology Examination Center (Obstetrics and Gynecology specialist) Graduated from Cha University Graduate School Adjunct Professor at Cha Medical University Center Leader of Hifu International Education Da Vinci Robotic Systems Certified Surgeon

Biography

Dr. Sagimole Tojichen is a Specialist Obstetrician and Gynecologist at Medeor Hospital in Dubai and a Gynae Laparoscopic Surgeon. With over 16 years of experience in Obstetrics and Gynecology, including 11 years in the United Arab Emirates. In 2002, she began her career as a Voluntary Lecturer at Alleppey Government Medical College in Kerala, India. She then joined Mother Hospital in Thrissur, Kerala, India, as a Specialist cum DNB Trainee. Later, she relocated to the United Arab Emirates, where she worked as a GP Obstetrician and Gynecologist at Medcare Hospital in Dubai. She trained in the same hospital as a Specialist Obstetrician and Gynecologist. She then accepted a position as a Specialist Obstetrician and Gynecologist, and Laparoscopic Surgeon at the International Modern Hospital (IMH) in Dubai, UAE. She earned a certificate in basic obstetric sonography and targeted sonography, including doppler and fetal diagnosis, basic and intermediate colposcopy training, focusing on vaginal surgeries, and diagnostic and operative hysteroscopy and laparoscopy training. 

Expertise

Obstetrics and Women Health:

• Normal and High-Risk Pregnancy Care and Delivery, Including Caesarean and Instrumental Deliveries
• Special Interest in Vaginal Birth after Caesarean
• Recurrent  Pregnancy Loss Care
• Adolescent Health
• Contraception, Including Copper T Insertion
• Preconception and Premarital Counselling
• Well Women Checkup and Cancer Screening of Breast and Uterus
• Treatment of Menopausal Problems
• Infertility Evaluation and Treatment
• Cerclage for Cervical Incompetence

Laparoscopic and Gynae Procedures:

• Total Laparoscopic Hysterectomy (Uterus Removal)
• Laparoscopic  Myomectomy (Fibroid Removal)
• Laparoscopic Surgery for Ovarian Cyst Removal
• Laparoscopic Treatment of Endometriosis
• Laparoscopic Surgery for Ectopic (Tubal) Pregnancy
• Fertility Enhancing Surgeries
• Surgical Correction of Urinary Incontinence
• Pelvic Floor Repair (Surgery for Uterine Prolapse and Vaginal Laxity)
• Colposcopy and LLETZ (Cervical Biopsy)
• Vaginal Surgeries
• Diagnostic Hysteroscopy (Endometrial Biopsy, Polypectomy Etc.)
• Operative Hysteroscopy – Synechiolysis, Myomectomy, Septal Resection

Membership

• Member of Royal College of Obstetricians and Gynecologists (UK)
• Dubai Health Authority
• Ministry of Health, UAE

Prof. M.D. Yusuf Serdar Sakin was born in Nevşehir in 1978. After completing his primary and secondary education in Ankara, he graduated from the Faculty of Medicine at Gülhane Military Medical Academy in 2002.
Following his graduation, he served in Gole/Ardahan for two years. He started his internal medicine training at the Department of Internal Medicine, Gülhane Faculty of Medicine.
After completing his training, he worked as an internal medicine specialist in Ankara. A year later, he began additional training in the Department of Gastroenterology at Gülhane Faculty of Medicine and completed his training in 2014.
After graduation, Yusuf Serdar Sakin continued to work in the same department. He also received advanced endoscopy and Motility training at AMC Center in the Netherlands in 2017.
After obtaining the title of Associate Professor in 2017, he became a Professor in 2023.
He currently provides medical services to patients at Koru Ankara Hospital. His areas of medical interest include:

-Endoscopic retrograde cholangiopancreatography (ERCP)
-Push enteroscopy
-Endoscopic mucosal resection
-High-resolution manometry
-pH/pH-impedance metry analysis
-Advanced endoscopic procedures (stenting, dilation, etc.)
-Gastrointestinal motility disorders
-Gastroesophageal reflux disease
-Inflammatory bowel diseases
-Advanced endoscopic procedures and pancreatitis.

Prof. Dr. Osman İLHAN graduated from Ankara University Faculty of Medicine in 1978. After completing his internal medicine residency at the same faculty in 1982, he served as a senior resident at the GATA Hematology Clinic during his military service. After completing his mandatory service at SSK Ulus Hospital, he returned to Ankara University Faculty of Medicine for a subspecialty. In 1990, he became an associate professor of hematology. He worked in Genoa, Italy to increase his knowledge and experience in leukemia. He was part of the team that performed the first bone marrow stem cell transplant in Turkey. In 1996, he went to the MD Anderson Cancer Center in the USA to work on "Stem Cell Mobilization, Cryopreservation, and Transplantation." In 1996, he became a professor of hematology. In 1999, he was elected as the regional president of ESFH (European Society for Hemapheresis). Dr. İlhan, who was the founder and president of the Hemapheresis Society in 2000, joined the World Apheresis Association (WAA) in 2001. He became the President of the Turkish Hematology Association in October 2001. Dr. İlhan, who is an active member of the European Hematology Association (EHA), was a member of the accreditation committee (ECAH) for education. He played a role in the accreditation of Turkish hematologists in CME credits by participating in the accreditation of congresses and courses held in Turkey as a Provider Status. He served as the founding president of the Cellular Therapy and Regenerative Medicine Association established in 2008. He became the founding president of the Geriatric Hematology Association in 2011. He is the Honorary President of the World Apheresis Congress (WAA) held in 2012. Dr. İlhan, who previously served on drug licensing and ethics committees at the Ministry of Health, has also served as the Chairman of the Photopheresis-Apheresis Commission and the Scientific Committee for Bone Marrow Transplantation, as well as the Chairman of the National Organ Tissue Cell Coordination Board, the Scientific Board of Cord Blood, and the Stem Cell Research Board. He is the founding president of the STEM CELL FOUNDATION and has played an important role in the establishment of TURKOK (Turkish Stem Cell Donor Bank). Dr. İlhan has over 300 publications in journals registered in PubMed and more than 5000 citations. He holds the Platinum CME certificate from the European Hematology Association. He owns four brands/patents named “Kökten Çözüm (Deep Solution), Telehematoloji (Telehematology), Hemaferez (Hemapheresis), Kanser Kök Hücresi (Cancer Stem Cell)”. He is currently the President of the Ankara Medical Association. Prof. Dr. Osman İlhan, who served at Ankara University Faculty of Medicine for 50 years, began working at Özel Koru Ankara Hospital as of January 1, 2023.

His medical interests include:

Hematopoietic Stem Cell Transplantation (Autologous, Allogeneic)

Acute Leukemia

Chronic Leukemia Treatments

Hodgkin Lymphoma

Non-Hodgkin Lymphoma Treatments

Multiple Myeloma Treatments, MDS

Aplastic Anemia

ITP

TTP Treatments

Hypercoagulability

Hereditary Thrombophilia Treatments

Therapeutic Apheresis

Photopheresis

Geriatric Hematology Diseases.

CV

Sema Yılmaz was born on July 30, 1965. She received her undergraduate degree from Istanbul University Cerrahpaşa Medical Faculty and completed her medical residency training at the Department of Pediatrics at Zeynep Kamil Women's and Children's Health and Diseases Hospital. She also completed her medical subspecialty training in Pediatric Hematology/Oncology at Cukurova University. Her medical residency thesis was titled "The Relationship Between Morning First Urine Density and Nocturnal Enuresis in Children Aged 3-6 Years", and her medical subspecialty thesis was titled "Comparison of Sphingosine 1-phosphate Receptor 4 Gene Expression in Healthy Children and Neuroblastoma Patients". She started her medical career as a general practitioner. After working as a general practitioner for 4 years, she worked as a doctor researcher at Zeynep Kamil Women's and Children's Health and Diseases Training and Research Hospital for 5 years. She then served as a specialist doctor, assistant professor, and associate professor at various institutions. She worked at Houston MD Anderson, North Carolina-UNC, Boston-Harvard University in the USA. Additionally, she conducted research on cell therapies. She received the title of professor in Pediatric Hematology/Oncology at Usak Medical Faculty. She is a member of the Turkish Pediatric Oncology Group, European Association for Cancer Research (EACR), Turkish Medical Association, Turkish National Pediatrics Association, Turkish Pediatrics Association, Pediatrics Specialty Academy Association (PUADER), Turkish Immunology Association, Turkish Hematology Association, and Molecular Oncology Association (MOKAD). She currently serves her patients at Koru Hospital. Her medical interests include:

Cell therapies in childhood cancers

Cancer immunology

Investigation of genetic pathways responsible for cancer and metastasis

Pulmonary microbiota

BAL transplantation